Lipid glycation and protein glycation in diabetes and atherosclerosis

Amino Acids

Volumn 42, Issue 4, 2012, Pages 1163-1170

  Miyazawa, Teruo ^a   Nakagawa, Kiyotaka ^a   Shimasaki, Satoko ^b   Nagai, Ryoji ^b  

^a TOHOKU UNIVERSITY   (Japan)

^b JAPAN WOMEN'S UNIVERSITY   (Japan)

Author keywords

AGE; Aldehydes; Atherosclerosis; Diabetes; Lipid glycation; Protein glycation

Indexed keywords

ADVANCED GLYCATION END PRODUCT; ADVANCED GLYCATION END PRODUCT RECEPTOR; BENFOTIAMINE; CHOLINE DERIVATIVE; DEOXY DEXTRO FRUCTOSYL PHOSPHATIDYLETHANOLAMINE; ETHANOLAMINE DERIVATIVE; PHOSPHATIDYLCHOLINE HYDROPEROXIDE; PHOSPHATIDYLETHANOLAMINE; PYRIDOXAL; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAMINE; UNCLASSIFIED DRUG; PROTEIN;

ATHEROGENESIS; ATHEROSCLEROSIS; CARBOHYDRATE ANALYSIS; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIABETOGENESIS; DIET SUPPLEMENTATION; GLYCATION; GLYCEMIC CONTROL; HUMAN; LIPID COMPOSITION; LIPID GLYCATION; LIPID PEROXIDATION; LIQUID CHROMATOGRAPHY; MOLECULAR INTERACTION; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OXIDATIVE STRESS; PHOSPHOLIPID BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN CROSS LINKING; PROTEIN GLYCOSYLATION; REVIEW; STREPTOZOCIN DIABETES; TANDEM MASS SPECTROMETRY; ANIMAL; GLYCOSYLATION; LIPID METABOLISM; METABOLISM; RAT;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS; GLYCOSYLATION; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; LIPID METABOLISM; PROTEINS; RATS;

EID: 84862643485     PISSN: 09394451     EISSN: 14382199     Source Type: Journal    
DOI: 10.1007/s00726-010-0772-3     Document Type: Review

References (46)

1. Araki N, Ueno N, Chakrabarti B, Morino Y, Horiuchi S (1992) Immunochemical evidence for the presence of advanced glycation end products in human lens proteins and its positive correlation with aging. J Biol Chem 267:10211-10214
2. Asai A, Okajima F, Nakagawa K, Ibusuki D, Tanimura K, Nakajima Y, NagaoM, SudoM, Harada T,Miyazawa T, Oikawa S (2009) Phosphatidylcholine hydroperoxide-induced THP-1 cell adhesion to intracellular adhesion molecule-1. J Lipid Res 50:957-965
3. Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405-412
4. Bucala R, Makita Z, Koschinsky T, Cerami A, Vlassara H (1993) Lipid advanced glycosylation: pathway for lipid oxidation in vivo. Proc Natl Acad Sci USA 90:6434-6438 (Pubitemid 23207227)
5. Cai W, He JC, Zhu L, Lu C, Vlassara H (2006) Advanced glycation end product (AGE) receptor 1 suppresses cell oxidant stress and activation signaling via EGF receptor. Proc Natl Acad Sci USA 103:13801-13806 (Pubitemid 44413988)
6. Hammes HP, Weiss A, Hess S, Araki N, Horiuchi S, Brownlee M, Preissner KT (1996) Modification of vitronectin by advanced glycation alters functional properties in vitro and in the diabetic retina. Lab Invest J Tech Methods Pathol 75:325-338 (Pubitemid 26314518)
7. Higashi T, Sano H, Saishoji T, Ikeda K, Jinnouchi Y, Kanzaki T, Morisaki N, Rauvala H, Shichiri M, Horiuchi S (1997) The receptor for advanced glycation end products mediates the chemotaxis of rabbit smooth muscle cells. Diabetes 46:463-472 (Pubitemid 27090277)
8. Higuchi O, Nakagawa K, Tsuzuki T, Suzuki T, Oikawa S, Miyazawa T (2006) Aminophospholipid glycation and its inhibitor screening system: a new role of pyridoxal 50-phosphate as the inhibitor. J Lipid Res 47:964-974 (Pubitemid 43764692)
9. Houjou T, Yamatani K, Nakanishi H, Imagawa M, Shimizu T, Taguchi R (2004) Rapid and selective identification of molecular species in phosphatidylcholine and sphingomyelin by conditional neutral loss scanning and MS3. Rapid Commun Mass Spectrom 18:3123-3130 (Pubitemid 39664916)
10. Hricik DE, Schulak JA, Sell DR, Fogarty JF, Monnier VM (1993) Effects of kidney or kidney-pancreas transplantation on plasma pentosidine. Kidney Int 43:398-403 (Pubitemid 23162833)
11. Imai N, Nishi S, Suzuki Y, Karasawa R, Ueno M, Shimada H, Kawashima S, Nakamaru T, Miyakawa Y, Araki N, Horiuchi S, Gejyo F, Arakawa M (1997) Histological localization of advanced glycosylation end products in the progression of diabetic nephropathy. Nephron 76:153-160 (Pubitemid 27254642)
12. Jinnouchi Y, Sano H, Nagai R, Hakamata H, Kodama T, Suzuki H, Yoshida M, Ueda S, Horiuchi S (1998) Glycolaldehyde-modified low density lipoprotein leads macrophages to foam cells via the macrophage scavenger receptor. J Biochem 123:1208-1217 (Pubitemid 28306006)
13. Kinoshita M, Oikawa S, Hayasaka K, Sekikawa A, Nagashima T, Toyota T, Miyazawa T (2000) Age-related increases in plasma phosphatidylcholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia. Clin Chem 46:822-828 (Pubitemid 30397446)
14. Kume S, Takeya M, Mori T, Araki N, Suzuki H, Horiuchi S, Kodama T, Miyauchi Y, Takahashi K (1995) Immunohistochemical and ultrastructural detection of advanced glycation end products in atherosclerotic lesions of human aorta with a novel specific monoclonal antibody. Am J Pathol 147:654-667
15. Lertsiri S, Shiraishi M, Miyazawa T (1998) Identification of deoxy-Dfructosyl phosphatidylethanolamine as a non-enzymic glycation product of phosphatidylethanolamine and its occurrence in human blood plasma and red blood cells. Biosci Biotechnol Biochem 62:893-901 (Pubitemid 128473711)
16. Mera K, Nagai R, Haraguchi N, Fujiwara Y, Araki T, Sakata N, Otagiri M (2007) Hypochlorous acid generates N epsilon- (carboxymethyl)lysine from Amadori products. Free Radic Res 41:713-718 (Pubitemid 46845592)
17. Mera K, Takeo K, Izumi M, Maruyama T, Nagai R, Otagiri M (2010) Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin. J Pharm Sci 99:1614-1625
18. Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T (1993) beta 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243-1252 (Pubitemid 23273898)
19. Miyata T, Taneda S, Kawai R, Ueda Y, Horiuchi S, Hara M, Maeda K, Monnier VM (1996) Identification of pentosidine as a native structure for advanced glycation end products in beta-2- microglobulin-containing amyloid fibrils in patients with dialysis- related amyloidosis. Proc Natl Acad Sci USA 93:2353-2358 (Pubitemid 26104354)
20. Miyazawa T (1989) Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC assay. Free Radic Biol Med 7:209-217 (Pubitemid 19220723)
21. Miyazawa T, Suzuki T, Fujimoto K, Yasuda K (1992) Chemiluminescent simultaneous determination of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide in the liver and brain of the rat. J Lipid Res 33:1051-1059
22. Nagai R, Ikeda K, Higashi T, Sano H, Jinnouchi Y, Araki T, Horiuchi S (1997) Hydroxyl radical mediates N epsilon-(carboxymethyl) lysine formation from Amadori product. Biochem Biophys Res Commun 234:167-172 (Pubitemid 27267554)
23. Nagai R, Matsumoto K, Ling X, Suzuki H, Araki T, Horiuchi S (2000) Glycolaldehyde, a reactive intermediate for advanced glycation end products, plays an important role in the generation of an active ligand for the macrophage scavenger receptor. Diabetes 49:1714-1723
24. Nagai R, Unno Y, Hayashi MC, Masuda S, Hayase F, Kinae N, Horiuchi S (2002) Peroxynitrite induces formation of N(epsilon)- (carboxymethyl) lysine by the cleavage of Amadori product and generation of glucosone and glyoxal from glucose: novel pathways for protein modification by peroxynitrite. Diabetes 51:2833-2839 (Pubitemid 34970938)
25. Nagai R, Mera K, Nakajou K, Fujiwara Y, Iwao Y, Imai H, Murata T, Otagiri M (2007) The ligand activity of AGE-proteins to scavenger receptors is dependent on their rate of modification by AGEs. Biochim Biophys Acta 1772:1192-1198 (Pubitemid 350245439)
26. Nagashima T, Oikawa S, Hirayama Y, Tokita Y, Sekikawa A, Ishigaki Y, Yamada R, Miyazawa T (2002) Increase of serum phosphatidylcholine hydroperoxide dependent on glycemic control in type 2 diabetic patients. Diabetes Res Clin Pract 56:19-25 (Pubitemid 34168516)
27. Nakagawa K, Oak JH, Higuchi O, Tsuzuki T, Oikawa S, Otani H, Mune M, Cai H, Miyazawa T (2005) Ion-trap tandem mass spectrometric analysis of Amadori-glycated phosphatidylethanolamine in human plasma with or without diabetes. J Lipid Res 46:2514-2524 (Pubitemid 41532540)
28. Nishikawa T, Edelstein D, Du XL, Yamagishi S, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, Brownlee M (2000) Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404:787-790 (Pubitemid 30212409)
29. Oak J, Nakagawa K, Miyazawa T (2000) Synthetically prepared Aamadori-glycated phosphatidylethanolaminecan trigger lipid peroxidation via free radical reactions. FEBS Lett 481:26-30 (Pubitemid 30662371)
30. Oak JH, Nakagawa K, Miyazawa T (2002) UV analysis of Amadoriglycated phosphatidylethanolamine in foods and biological samples. J Lipid Res 43:523-529 (Pubitemid 34252282)
31. Oak JH, Nakagawa K, Oikawa S, Miyazawa T (2003) Amadoriglycated phosphatidylethanolamine induces angiogenic differentiations in cultured human umbilical vein endothelial cells. FEBS Lett 555:419-423 (Pubitemid 37486066)
32. Odetti P, Fogarty J, Sell DR, Monnier VM (1992) Chromatographic quantitation of plasma and erythrocyte pentosidine in diabetic and uremic subjects. Diabetes 41:153-159
33. Ravandi A, Kuksis A, Marai L, Myher JJ (1995) Preparation and characterization of glucosylated aminoglycerophospholipids. Lipids 30:885-891
34. Schmidt AM, Vianna M, Gerlach M, Brett J, Ryan J, Kao J, Esposito C, Hegarty H, Hurley W, Clauss M et al (1992) Isolation and characterization of two binding proteins for advanced glycosylation end products from bovine lung which are present on the endothelial cell surface. J Biol Chem 267:14987-14997
35. Schmidt AM, Hori O, Chen JX, Li JF, Crandall J, Zhang J, Cao R, Yan SD, Brett J, Stern D (1995) Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of diabetes. J Clin Invest 96:1395-1403
36. Sell DR, Monnier VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264:21597-21602 (Pubitemid 20028722)
37. Shoji N, Nakagawa K, Asai A, Fujita I, Hashiura A, Nakajima Y, Oikawa S, Miyazawa T (2010) LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma. J Lipid Res 51(8):2445-2453 in press)
38. (in press) Smith MA, Taneda S, Richey PL, Miyata S, Yan SD, Stern D, Sayre LM, Monnier VM, Perry G (1994) Advanced Maillard reaction end products are associated with Alzheimer disease pathology. Proc Natl Acad Sci USA 91:5710-5714 (Pubitemid 24174398)
39. Takeuchi M, Yamagishi S (2004) Alternative routes for the formation of glyceraldehyde-derived AGEs (TAGE) in vivo. Med Hypotheses 63:453-455 (Pubitemid 38993610)
40. Taneda S, Monnier VM (1994) ELISA of pentosidine, an advanced glycation end product, in biological specimens. Clin Chem 40:1766-1773 (Pubitemid 24273103)
41. Thornalley PJ, Argirova M, Ahmed N, Mann VM, Argirov O, Dawnay A (2000) Mass spectrometric monitoring of albumin in uremia. Kidney Int 58:2228-2234
42. Tokita Y, Hirayama Y, Sekikawa A, Kotake H, Toyota T, Miyazawa T, Sawai T, Oikawa S (2005) Fructose ingestion enhances atherosclerosis and deposition of advanced glycated end-products in cholesterol-fed rabbits. J Atheroscler Thromb 12:260-267
43. Utzmann CM, Lederer MO (2000) Identification and quantification of aminophospholipid-linked Maillard compounds in model systems and egg yolk products. J Agric Food Chem 48:1000-1008 (Pubitemid 30243654)
44. Vlassara H, Fuh H, Makita Z, Krungkrai S, Cerami A, Bucala R (1992) Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications. Proc Natl Acad Sci USA 89:12043-12047 (Pubitemid 23004781)
45. Witztum JL, Steinberg D (1991) Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 88:1785-1792
46. Yamada K, Miyahara Y, Hamaguchi K, Nakayama M, Nakano H, Nozaki O, Miura Y, Suzuki S, Tuchida H, Mimura N et al (1994) Immunohistochemical study of human advanced glycosylation endproducts (AGE) in chronic renal failure. Clin Nephrol 42:354-361